The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Diabetes Management Market Research Report 2024
Synopsis
Diabetes, scientifically known as diabetes mellitus, is a clinical condition where person has an elevated blood glucose level.
The global Diabetes Management market was valued at US$ 5369 million in 2023 and is anticipated to reach US$ 13150 million by 2030, witnessing a CAGR of 13.5% during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Diabetes Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Management.
Report Scope
The Diabetes Management market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetes Management market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Management companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ascensia Diabetes Care
Abbott Laboratories
Medtronic
Roche
Dexcom
Insulet Corporation
Tandem Diabetes Care
LifeScan
AgaMatrix
Animas
ARKRAY
BD
Beta Bionics.
Eli Lilly
Segment by Type
Monitoring Devices
Diagnostic Devices
Insulin Delivery Devices
Other Devices
Segment by Application
Hospital
Clinic
Home Care
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetes Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Diabetes, scientifically known as diabetes mellitus, is a clinical condition where person has an elevated blood glucose level.
The global Diabetes Management market was valued at US$ 5369 million in 2023 and is anticipated to reach US$ 13150 million by 2030, witnessing a CAGR of 13.5% during the forecast period 2024-2030.
According to the Global Use of Medicines 2023 released by IQVIA Institute, the global drug expenditure in 2022 was about US$1.48 trillion (excluding COVID vaccine and treatment-related expenses), and it is predicted to grow at a rate of 3%-6% in the next few years. In terms of drug expenditure, this number in China was about 166 billion dollars in 2022. It is expected that the expenditure on medicines will increase in the next few years. From the perspective of demand, the trend of population aging, the increase of residents’ wealth and the improvement of health awareness will drive the demand for medicines.
Global Use of Medicines 2023 shows that the U.S. market spent about US$ 62.9 billion on medicines in 2022 on a net ex-factory basis. Overall growth slows as the Inflation Reduction Act (IRA) spends US$64 billion to reduce prescription drug prices, and the adoption of new treatments is expected to increase over the next few years. Besides, ex-factory discounts and rebates in drug distribution, the impact of patent expiration, and generic or biosimilar competition will also affect the U.S. pharmaceutical market.
This report aims to provide a comprehensive presentation of the global market for Diabetes Management, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Diabetes Management.
Report Scope
The Diabetes Management market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Diabetes Management market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Diabetes Management companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Ascensia Diabetes Care
Abbott Laboratories
Medtronic
Roche
Dexcom
Insulet Corporation
Tandem Diabetes Care
LifeScan
AgaMatrix
Animas
ARKRAY
BD
Beta Bionics.
Eli Lilly
Segment by Type
Monitoring Devices
Diagnostic Devices
Insulin Delivery Devices
Other Devices
Segment by Application
Hospital
Clinic
Home Care
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Diabetes Management companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Diabetes Management Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monitoring Devices
1.2.3 Diagnostic Devices
1.2.4 Insulin Delivery Devices
1.2.5 Other Devices
1.3 Market by Application
1.3.1 Global Diabetes Management Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Diabetes Management Market Perspective (2019-2030)
2.2 Diabetes Management Growth Trends by Region
2.2.1 Global Diabetes Management Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Diabetes Management Historic Market Size by Region (2019-2024)
2.2.3 Diabetes Management Forecasted Market Size by Region (2025-2030)
2.3 Diabetes Management Market Dynamics
2.3.1 Diabetes Management Industry Trends
2.3.2 Diabetes Management Market Drivers
2.3.3 Diabetes Management Market Challenges
2.3.4 Diabetes Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Diabetes Management Players by Revenue
3.1.1 Global Top Diabetes Management Players by Revenue (2019-2024)
3.1.2 Global Diabetes Management Revenue Market Share by Players (2019-2024)
3.2 Global Diabetes Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Diabetes Management Revenue
3.4 Global Diabetes Management Market Concentration Ratio
3.4.1 Global Diabetes Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Diabetes Management Revenue in 2023
3.5 Diabetes Management Key Players Head office and Area Served
3.6 Key Players Diabetes Management Product Solution and Service
3.7 Date of Enter into Diabetes Management Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Diabetes Management Breakdown Data by Type
4.1 Global Diabetes Management Historic Market Size by Type (2019-2024)
4.2 Global Diabetes Management Forecasted Market Size by Type (2025-2030)
5 Diabetes Management Breakdown Data by Application
5.1 Global Diabetes Management Historic Market Size by Application (2019-2024)
5.2 Global Diabetes Management Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Diabetes Management Market Size (2019-2030)
6.2 North America Diabetes Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Diabetes Management Market Size by Country (2019-2024)
6.4 North America Diabetes Management Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Diabetes Management Market Size (2019-2030)
7.2 Europe Diabetes Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Diabetes Management Market Size by Country (2019-2024)
7.4 Europe Diabetes Management Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Diabetes Management Market Size (2019-2030)
8.2 Asia-Pacific Diabetes Management Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Diabetes Management Market Size by Region (2019-2024)
8.4 Asia-Pacific Diabetes Management Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Diabetes Management Market Size (2019-2030)
9.2 Latin America Diabetes Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Diabetes Management Market Size by Country (2019-2024)
9.4 Latin America Diabetes Management Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Diabetes Management Market Size (2019-2030)
10.2 Middle East & Africa Diabetes Management Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Diabetes Management Market Size by Country (2019-2024)
10.4 Middle East & Africa Diabetes Management Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Ascensia Diabetes Care
11.1.1 Ascensia Diabetes Care Company Detail
11.1.2 Ascensia Diabetes Care Business Overview
11.1.3 Ascensia Diabetes Care Diabetes Management Introduction
11.1.4 Ascensia Diabetes Care Revenue in Diabetes Management Business (2019-2024)
11.1.5 Ascensia Diabetes Care Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Diabetes Management Introduction
11.2.4 Abbott Laboratories Revenue in Diabetes Management Business (2019-2024)
11.2.5 Abbott Laboratories Recent Development
11.3 Medtronic
11.3.1 Medtronic Company Detail
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Diabetes Management Introduction
11.3.4 Medtronic Revenue in Diabetes Management Business (2019-2024)
11.3.5 Medtronic Recent Development
11.4 Roche
11.4.1 Roche Company Detail
11.4.2 Roche Business Overview
11.4.3 Roche Diabetes Management Introduction
11.4.4 Roche Revenue in Diabetes Management Business (2019-2024)
11.4.5 Roche Recent Development
11.5 Dexcom
11.5.1 Dexcom Company Detail
11.5.2 Dexcom Business Overview
11.5.3 Dexcom Diabetes Management Introduction
11.5.4 Dexcom Revenue in Diabetes Management Business (2019-2024)
11.5.5 Dexcom Recent Development
11.6 Insulet Corporation
11.6.1 Insulet Corporation Company Detail
11.6.2 Insulet Corporation Business Overview
11.6.3 Insulet Corporation Diabetes Management Introduction
11.6.4 Insulet Corporation Revenue in Diabetes Management Business (2019-2024)
11.6.5 Insulet Corporation Recent Development
11.7 Tandem Diabetes Care
11.7.1 Tandem Diabetes Care Company Detail
11.7.2 Tandem Diabetes Care Business Overview
11.7.3 Tandem Diabetes Care Diabetes Management Introduction
11.7.4 Tandem Diabetes Care Revenue in Diabetes Management Business (2019-2024)
11.7.5 Tandem Diabetes Care Recent Development
11.8 LifeScan
11.8.1 LifeScan Company Detail
11.8.2 LifeScan Business Overview
11.8.3 LifeScan Diabetes Management Introduction
11.8.4 LifeScan Revenue in Diabetes Management Business (2019-2024)
11.8.5 LifeScan Recent Development
11.9 AgaMatrix
11.9.1 AgaMatrix Company Detail
11.9.2 AgaMatrix Business Overview
11.9.3 AgaMatrix Diabetes Management Introduction
11.9.4 AgaMatrix Revenue in Diabetes Management Business (2019-2024)
11.9.5 AgaMatrix Recent Development
11.10 Animas
11.10.1 Animas Company Detail
11.10.2 Animas Business Overview
11.10.3 Animas Diabetes Management Introduction
11.10.4 Animas Revenue in Diabetes Management Business (2019-2024)
11.10.5 Animas Recent Development
11.11 ARKRAY
11.11.1 ARKRAY Company Detail
11.11.2 ARKRAY Business Overview
11.11.3 ARKRAY Diabetes Management Introduction
11.11.4 ARKRAY Revenue in Diabetes Management Business (2019-2024)
11.11.5 ARKRAY Recent Development
11.12 BD
11.12.1 BD Company Detail
11.12.2 BD Business Overview
11.12.3 BD Diabetes Management Introduction
11.12.4 BD Revenue in Diabetes Management Business (2019-2024)
11.12.5 BD Recent Development
11.13 Beta Bionics.
11.13.1 Beta Bionics. Company Detail
11.13.2 Beta Bionics. Business Overview
11.13.3 Beta Bionics. Diabetes Management Introduction
11.13.4 Beta Bionics. Revenue in Diabetes Management Business (2019-2024)
11.13.5 Beta Bionics. Recent Development
11.14 Eli Lilly
11.14.1 Eli Lilly Company Detail
11.14.2 Eli Lilly Business Overview
11.14.3 Eli Lilly Diabetes Management Introduction
11.14.4 Eli Lilly Revenue in Diabetes Management Business (2019-2024)
11.14.5 Eli Lilly Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
